ABIODUN OLATIDOYE, M.D.
Cardiovascular Disease Physician in RIVERDALE, Georgia. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
ABIODUN OLATIDOYE, M.D. reported a CMS MIPS final score of 92.2614/100 — above the 83.1 national average — and filed 5,003 Medicare Part D claims in 2023.
- 92.2614/100
- MIPS score · +9 vs avg
- 5K
- Part D claims, 2023
- 89%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
ABIODUN OLATIDOYE, M.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure
92 Top 32% higher than 68% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
ABIODUN OLATIDOYE, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about ABIODUN OLATIDOYE, M.D.?
High performer (top quartile)Primary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Georgia
How Cardiovascular Disease Physician compares to other specialties among Georgia providers
Cardiovascular Disease Physician share within Georgia
Cardiovascular Disease Physician is one of the more visible NUCC categories in Georgia
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
ABIODUN OLATIDOYE, M.D.'s 2023 MIPS final score plotted against the Cardiovascular Disease Physician national average
- MIPS Final Score
- 92.2614/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Cardiovascular Disease Physician) — 92.2614/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Specialty volume Cardiovascular Disease Physician US NPIs
92.2614/100 MIPS final score — 9.2 pts above the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Cardiovascular Disease Physician. Quality dim: 73.8353.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
ABIODUN OLATIDOYE, M.D. appears in the CMS NPPES registry as a Cardiovascular Disease Physician provider holding M.D. credentials at 6507 PROFESSIONAL PL, RIVERDALE, GA, 30274, with a listed phone of (770) 991-2100. NPI 1659334209 was issued on 04/06/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what OLATIDOYE most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 5,003 prescription claims written by this provider, covering 650 Medicare beneficiaries and totaling roughly $590K in drug spend, split 11% brand-name and 89% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 92.2614/100 for the 2023 performance year (Quality 73.8353), compared with the national average of 83.1.
Cardiovascular Disease Physician is a mid-sized specialty nationwide, with 24,795 enrolled providers across 54 states and an average of 3,033 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1659334209 |
|---|---|
| Specialty | Cardiovascular Disease Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 04/06/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm ABIODUN OLATIDOYE, M.D.'s current license status, disciplinary history, and board certifications with the Georgia Composite Medical Board in Georgia before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Alternative Payment Model
Hospital and facility affiliations
Facilities where ABIODUN OLATIDOYE, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Brand vs generic prescribing mix · Typical
11% brand-name claims vs 89% generic, on 5,003 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 12,243
- Total Day Supply
- 365,200
- Brand vs Generic
- 11% brand / 89% generic
- Brand Drug Cost
- $494K
- Generic Drug Cost
- $96K
Patient Demographics
- Average Patient Age
- 73.0 years
- Avg HCC Risk Score
- 1.74
- Gender Split
- 60% female / 40% male
- Age Distribution
- <65: 86, 65-74: 278, 75-84: 219, 85+: 67
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What ABIODUN OLATIDOYE, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Metoprolol Succinate
Metoprolol Succinate
481 claims
- Atorvastatin Calcium
Atorvastatin Calcium
452 claims
- Amlodipine Besylate
Amlodipine Besylate
424 claims
- Eliquis
Eliquis
299 claims
- Isosorbide Mononit…
Isosorbide Mononitrate Er
235 claims
- Carvedilol
Carvedilol
222 claims
- Lisinopril 191
Lisinopril
191 claims
- Hydralazine Hcl 178
Hydralazine Hcl
178 claims
| Drug | Claims |
|---|---|
| Metoprolol Succinate | 481 |
| Atorvastatin Calcium | 452 |
| Amlodipine Besylate | 424 |
| Eliquis Apixaban | 299 |
| Isosorbide Mononitrate Er Isosorbide Mononitrate | 235 |
| Carvedilol | 222 |
| Lisinopril | 191 |
| Hydralazine Hcl | 178 |
| Valsartan | 174 |
| Furosemide | 169 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Cardiovascular Disease Physician Overview
How ABIODUN OLATIDOYE, M.D. fits within the Cardiovascular Disease Physician landscape nationally.
ABIODUN OLATIDOYE, M.D.'s 5,003 claims are above the specialty average of 3,033.
Nearby Cardiovascular Disease Physician Providers in Georgia
Other clinicians with the same primary specialty enrolled in Georgia, drawn from the same CMS NPPES roster as OLATIDOYE.
Compare Cardiovascular Disease Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Georgia
Frequently Asked Questions
What is ABIODUN OLATIDOYE, M.D.'s specialty? ▼
How much does ABIODUN OLATIDOYE, M.D. prescribe under Medicare Part D? ▼
What is ABIODUN OLATIDOYE, M.D.'s Medicare quality score? ▼
Where is ABIODUN OLATIDOYE, M.D. located? ▼
What is ABIODUN OLATIDOYE, M.D.'s NPI number? ▼
Does ABIODUN OLATIDOYE, M.D. prescribe more brand-name or generic drugs? ▼
How many Cardiovascular Disease Physician providers are there in the US? ▼
What drugs does ABIODUN OLATIDOYE, M.D. prescribe most often? ▼
Does ABIODUN OLATIDOYE, M.D. accept Medicare? ▼
How can I verify ABIODUN OLATIDOYE, M.D.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology